Survivin Determines Cardiac Function by Controlling Total Cardiomyocyte Number

Background— Survivin inhibits apoptosis and regulates cell division in many organs, but its function in the heart is unknown. Methods and Results— We show that cardiac-specific deletion of survivin resulted in premature cardiac death. The underlying cause was a dramatic reduction in total cardiomyocyte numbers as determined by a stereological method for quantification of cells per organ. The resulting increased hemodynamic load per cell led to progressive heart failure as assessed by echocardiography, magnetic resonance imaging, positron emission tomography, and invasive catheterization. The reduction in total cardiomyocyte number in α-myosin heavy chain (MHC)–survivin−/− mice was due to an ≈50% lower mitotic rate without increased apoptosis. This occurred at the expense of DNA accumulation because survivin-deficient cardiomyocytes displayed marked DNA polyploidy indicative of consecutive rounds of DNA replication without cell division. Survivin small interfering RNA knockdown in neonatal rat cardiomyocytes also led to polyploidization and cell cycle arrest without apoptosis. Adenoviral overexpression of survivin in cardiomyocytes inhibited doxorubicin-induced apoptosis, induced DNA synthesis, and promoted cell cycle progression. The phenotype of the αMHC-survivin−/− mice also allowed us to determine the minimum cardiomyocyte number sufficient for normal cardiac function. In human cardiomyopathy, survivin was potently induced in the failing heart and downregulated again after hemodynamic support by a left ventricular assist device. Its expression positively correlated with the mean cardiomyocyte DNA content. Conclusions— We suggest that the ontogenetically determined cardiomyocyte number may be an independent factor in the susceptibility to cardiac diseases. Through its profound impact on both cardiomyocyte replication and apoptosis, survivin may emerge as a promising new target for myocardial regeneration.

[1]  R. Agami,et al.  Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension , 2003, The EMBO journal.

[2]  William C Earnshaw,et al.  Survivin is required for stable checkpoint activation in taxol-treated HeLa cells , 2003, Journal of Cell Science.

[3]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Leevers,et al.  Controlling the size of organs and organisms. , 2005, Current opinion in cell biology.

[5]  G. Haroske,et al.  Part I: Basic Considerations and Recommendations for Preparation, Measurement and Interpretation , 1998, Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology.

[6]  G. Biondi-Zoccai,et al.  Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction , 2004, Journal of Clinical Pathology.

[7]  B. A. French,et al.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.

[8]  M. Buckingham,et al.  The clonal origin of myocardial cells in different regions of the embryonic mouse heart. , 2004, Developmental cell.

[9]  C. ffrench-Constant,et al.  The control of cell number during central nervous system development in flies and mice , 2003, Mechanisms of Development.

[10]  G Haroske,et al.  1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. , 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[11]  J. Fangusaro,et al.  Essential Role for Survivin in Early Brain Development , 2005, The Journal of Neuroscience.

[12]  M. Fey,et al.  Inflammation-associated Cell Cycle–independent Block of Apoptosis by Survivin in Terminally Differentiated Neutrophils , 2004, The Journal of experimental medicine.

[13]  Tak W. Mak,et al.  Pathways of apoptotic and non-apoptotic death in tumour cells , 2004, Nature Reviews Cancer.

[14]  C. Adler,et al.  Variability of cardiomyocyte DNA content, ploidy level and nuclear number in mammalian hearts , 1996, Virchows Archiv.

[15]  A. Winoto,et al.  Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis , 2004, The Journal of experimental medicine.

[16]  John Calvin Reed,et al.  HBXIP functions as a cofactor of survivin in apoptosis suppression , 2003, The EMBO journal.

[17]  D. Vaux,et al.  Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype , 2000, Current Biology.

[18]  E. Ritz,et al.  Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension , 2003, Virchows Archiv.

[19]  Michael Schäfers,et al.  Lack of Myoglobin Causes a Switch in Cardiac Substrate Selection , 2005, Circulation research.

[20]  John Miller,et al.  Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. , 2006, International journal of cardiology.

[21]  Atsushi Takeda,et al.  Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. , 2005, Cardiovascular research.

[22]  R. Altura,et al.  Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. , 2007, Blood.

[23]  R. Kitsis,et al.  A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.

[24]  Richard T. Lee,et al.  Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. , 2005, The Journal of clinical investigation.

[25]  J. Ingelfinger,et al.  Is microanatomy destiny? , 2003, The New England journal of medicine.

[26]  Guido Kroemer,et al.  Cell death by mitotic catastrophe: a molecular definition , 2004, Oncogene.

[27]  P. Taylor,et al.  Experimental models of developmental programming: consequences of exposure to an energy rich diet during development , 2005, The Journal of physiology.

[28]  Richard T. Lee,et al.  Biomechanically Induced Gene iex-1 Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation , 2003, Circulation research.

[29]  W. Sandritter,et al.  Deoxyribonucleic Acid Content (Feulgen Photometry) and Dry Weight (Interference Microscopy) of Normal and Hypertrophic Heart Muscle Fibres , 1964, Nature.

[30]  J. Fischer,et al.  Integrin-Mediated Transcriptional Activation of Inhibitor of Apoptosis Proteins Protects Smooth Muscle Cells Against Apoptosis Induced by Degraded Collagen , 2006, Circulation research.

[31]  N. Hollenberg,et al.  Nephron number in patients with primary hypertension. , 2003, Current hypertension reports.

[32]  S. Vatner,et al.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.

[33]  C. Mantel,et al.  Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. , 2004, Blood.

[34]  David L. Vaux,et al.  IAPs, RINGs and ubiquitylation , 2005, Nature Reviews Molecular Cell Biology.

[35]  Xuebiao Yao,et al.  Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis* , 2003, Journal of Biological Chemistry.

[36]  D. Altieri Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm , 2004, Journal of cellular biochemistry.

[37]  Anjen Chenn,et al.  Regulation of Cerebral Cortical Size by Control of Cell Cycle Exit in Neural Precursors , 2002, Science.

[38]  P. Anversa,et al.  Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. , 2003, Circulation research.

[39]  J. Narula,et al.  Apoptosis and heart failure: clinical relevance and therapeutic target. , 2005, Journal of molecular and cellular cardiology.

[40]  J. Spears,et al.  Intracoronary aqueous oxygen perfusion, performed 24 h after the onset of postinfarction reperfusion, experimentally reduces infarct size and improves left ventricular function. , 2006, International journal of cardiology.

[41]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.